Publications

Gallegos Saliner A, Patlewicz G, Worth AP. 2006. Review of Literature-Based Models for Skin and Eye Irritation and Corrosion. EUR 22320 EN.

Ferriby LL, Franke K, Unice KM, Scott P, Haws LC, Harris M, Paustenbach DJ. 2006. Serum reference levels of PCDD/Fs and dioxin-like PCBs stratified by race/ethnicity, gender and age for the general U.S. population. American Public Health Association Annual Meeting and Exposition. November 4-8, 2006. Boston, MA.

Mandel JH, Kelsh MA, Mink PJ, Alexander D, Kalmes RM, Weingart M, et al. 2006. Occupational trichloroethylene exposure and non-Hodgkins lymphoma: A meta-analysis and review. Occup Environ Med 63(9):597–607; doi: 10.1136/oem.2005.022418. PMID: 16644896.

Robison TW. Toxicology in the nonclinical development of drugs and biologics. Pharmaceutical Education and Research Institute, Genetic Toxicology, Arlington, VA, September 2006.

Finster M, MacDonell M, Bhattacharyya M, Haroun L, Peterson J, Perry C. Environmental fate and cumulative risk context for cleanup programs. Society for Risk Analysis Annual Meeting. Baltimore, MD, December 2006.

Staskal DF, Diliberto JJ, Birnbaum LS. 2006. Impact of repeated exposure on the toxicokinetics of BDE 47 in mice. Toxicol Sci 89(2):380-5; doi: 10.1093/toxsci/kfj038.

Paustenbach DJ, Gaffney SA, Scott PK, Brown JL, Panko JM. High background levels of urinary benzene metabolites found in volunteer study. Society of Toxicology 45th Annual Meeting, San Diego, CA, 2006.

Paustenbach DJ, Panko JM, Scott PK, Unice KM. Retrospective modeling of potential residential exposure to perfluorooctanoic acid (PFOA) releases from a manufacturing facility. Society of Toxicology 45th Annual Meeting, San Diego, CA, March 2006.

Panko JM, Shay EC. Potential for airborne dispersion of bromadiolone and exposure in an office setting. International Society for Exposure Assessment Conference, 2006.

Panko JM, Unice KM, Shay EC, Price P. Assessment of children’s exposures to xylenes. International Society for Exposure Assessment Conference, 2006.

Panko JM, Unice KM, Shay EC, Javier AF. Assessment of children’s exposures to benzene. Society for Risk Analysis, December 2006.

Staskal DF, Diliberto JJ, Birnbam LS. 2006. Disposition of BDE 47 in developing mice. Toxicol Sci 90(2):309-16; doi: 10.1093/toxsci/kfj098.

David RM, Clewell HJ, Gentry PR, Covington TR, Morgott DA, Marino DJ. 2006. Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations. Regul Toxicol Pharmacol 45(1):55–65; doi: 10.1016/j.yrtph.2005.12.003.

Marino DJ, Clewell HJ, Gentry PR, Covington TR, Hack CE, David RM, Morgott DA. 2006. Revised assessment of cancer risk to dichloromethane: Part I Bayesian PBPK and dose-response modeling in mice. Regul Toxicol Pharmacol 45(1):44–54; doi: 10.1016/j.yrtph.2005.12.007.

Degregorio MW, Dingley KH, Wurz GT, Ubick E, Turteltaub KW. 2006. Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrations. Cancer Chemother Pharmacol 57(3):335-342; doi: 10.1007/s00280-005-0060-1. PMID: 16047147.

Tompkins EM, Farmer PB, Lamb JH, Jukes R, Dingley K, Ubick E, et al. 2006. A novel 14C-postlabeling assay using accelerator mass spectrometry for the detection of O6-methyldeoxy-guanosine adducts. Rapid Commun Mass Spectrom 20(5):883–891; doi: 10.1002/rcm.2370. PMID: 16470516.

Borowsky AD, Dingley KH, Ubick E, Turteltaub KW, Cardiff RD, Devere-White R. 2006. Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model. Neoplasia 8(9):708–715; doi: 10.1593/neo.06373. PMID: 16984728.

Malfatti MA, Dingley KH, Nowell-Kadlubar S, Ubick EA, Mulakken N, Nelson D, Lang NP, et al. 2006. The urinary metabolite profile of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is predictive of colon DNA adducts after a low-dose exposure in humans. Cancer Res 66(21):10541–10547; doi: 10.1158/0008-5472.CAN-06-1573. PMID: 17079477.

Lau C, Thibodeaux JR, Hanson RG, Narotsky MG, Rogers JM, Lindstrom AB, Strynar MJ. 2006. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 90(2):510–518; doi: 10.1093/toxsci/kfj105.

Haws L. The use of toxic equivalency factors to assess potential human health risks posed by dioxin-like compounds: Keeping up with the science. Presented at Michigan State University, Toxicology Program Seminar Series, September,, 2006.